Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ISTODAX
- Romidepsin and Parsaclisib for the Treatment of Relapsed or Refractory T-Cell Lymphomas
- Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer
- Copanlisib in Combination With Romidepsin in Patients With Relapsed or Refractory Mature T-cell Lymphoma
- Efficacy and Safety of Oral Azacitidine Compared to Investigator's Choice Therapy in Patients With Relapsed or Refractory AITL
- Study of Ixazomib and Romidepsin in Peripheral T-cell Lymphoma (PTCL)
- Venetoclax and Romidepsin in Treating Patients With Recurrent or Refractory Mature T-Cell Lymphoma
- Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast Cancer
- Romidepsin Versus Combination of Romidepsin Plus Pralatrexate in PTCL
- Study of Pembrolizumab (MK-3475) in Combination With Romidepsin
- Evaluation of the Combination of Romidepsin and Carfilzomib in Relapsed/Refractory Peripheral T Cell Lymphoma Patients
- Early Administration of Romidepsin and 3BNC117 in Treatment-naïve HIV Patients Starting ART
- Romidepsin Maintenance After Allogeneic Stem Cell Transplantation
- A Study of Enhancing Response to MK-3475 in Advanced Colorectal Cancer
- Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma
- Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma
- Romidepsin in Treating Patients With Steroid-Refractory Graft-versus-Host Disease
- Phase I Study of Romidepsin, Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed/Refractory Aggressive Lymphomas
- Poly ICLC, Radiation, and Romidepsin for Advanced Cutaneous T Cell Lymphoma
- Romidepsin Plus Oral 5-Azacitidine in Relapsed/Refractory Lymphoid Malignancies
- Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies
- Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast Cancer
- Evaluating the Safety and Efficacy of Romidepsin in Combination With Antiretroviral Therapy in HIV-Infected Adults With Suppressed Viral Load
- A Pilot Study of Romidepsin in Relapsed or Refractory Extranodal NK/T-cell Lymphoma
- Phase I Dose-finding and Preliminary Efficacy Study of the Istodax® in Combination With Doxil® for the Treatment of Adults With Relapsed or Refractory Cutaneous T-cell Lymphoma
- Alisertib and Romidepsin in Treating Patients With Relapsed or Refractory B-Cell or T-Cell Lymphomas
- An Open Label, International, Multi-centre, Phase I/IIa Study of Lenalidomide (Revlimid) and Romidepsin (Istodax) for Relapsed /Refractory Hodgkin Lymphoma, Mature T-cell Lymphoma and Multiple Myeloma. (RId Study)
- Dose-Escalation Trial of Carfilzomib With and Without Romidepsin in Cutaneous T-Cell Lymphoma
- Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
- Romidepsin, Ifosfamide, Carboplatin, and Etoposide in Treating Participants With Relapsed or Refractory Peripheral T-Cell Lymphoma
- A Trial of Oral 5-azacitidine in Combination With Romidepsin in Advanced Solid Tumors, With an Expansion Cohort in Virally Mediated Cancers and Liposarcoma
- A Study of Escalating Doses of Romidepsin in Association With CHOP in the Treatment of Peripheral T-Cell Lymphomas
- A Trial of Romidepsin for Progressive or Relapsed Peripheral T-cell Lymphoma
- FR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
- Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma
- A Research Study for Patients With Prostate Cancer
- Romidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive Iodine
- FR901228 in Treating Patients With Refractory Stomach Cancer or Gastroesophageal Junction Cancer
- FR901228 in Treating Patients With Metastatic Breast Cancer
- Depsipeptide (Romidepsin) in Treating Patients With Recurrent Ovarian Epithelial or Peritoneal Cavity Cancer
- Romidepsin in Treating Patients With Relapsed Small Cell Lung Cancer
- FR901228 in Treating Patients With Recurrent High-Grade Gliomas
- Depsipeptide in Unresectable Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
- Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors
- FR901228 Alone or Combined With Rituximab and Fludarabine in Treating Patients With Relapsed or Refractory Low-Grade B-Cell Non-Hodgkin's Lymphoma
- Romidepsin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia
Clinical trials list
click for details